Dutch Heath Minister Accused Of Polarizing Medicine Price Debate
Executive Summary
Dutch Health Minister Bruno Bruins has attacked pharmaceutical companies over their drug pricing practices, and has threatened to name and shame one particular firm.
You may also be interested in...
The Netherlands Swaps Germany For Norway To Set Prices
The Netherlands will secure lower medicine prices by referencing Norway instead of Germany to set maximum prices.
New Dutch ‘Excessive Price’ Watchdog Targets Leadiant’s Orphan Drug
A new Dutch foundation set up to address cases of what it says are excessive drug pricing says it plans to refer Leadiant Biosciences’ CDCA product for the rare genetic disease, cerebrotendinous xanthomatosis, to the competition authorities.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.